Trial · NCT05093790
Adverse events28
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 28
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Increased tendency to bruise | Blood and lymphatic system disorders | Arm 1: 90 mg Ticagrelor + 4 mg BMS-986141 | 1 | 16 | |
| other | Increased tendency to bruise | Blood and lymphatic system disorders | Arm 2: 75 mg Aspirin + 4 mg BMS-986141 | 0 | 15 | |
| other | Increased tendency to bruise | Blood and lymphatic system disorders | Arm 3: 90 mg Ticagrelor + 75 mg Aspirin + 4 mg BMS-986141 | 1 | 16 | |
| other | Increased tendency to bruise | Blood and lymphatic system disorders | Arm 4: Heathy Participants | 0 | 11 | |
| other | Diarrhoea | Gastrointestinal disorders | Arm 1: 90 mg Ticagrelor + 4 mg BMS-986141 | 1 | 16 | |
| other | Diarrhoea | Gastrointestinal disorders | Arm 2: 75 mg Aspirin + 4 mg BMS-986141 | 0 | 15 | |
| other | Diarrhoea | Gastrointestinal disorders | Arm 3: 90 mg Ticagrelor + 75 mg Aspirin + 4 mg BMS-986141 | 1 | 16 | |
| other | Diarrhoea | Gastrointestinal disorders | Arm 4: Heathy Participants | 0 | 11 | |
| other | COVID-19 | Infections and infestations | Arm 1: 90 mg Ticagrelor + 4 mg BMS-986141 | 2 | 16 | |
| other | COVID-19 | Infections and infestations | Arm 2: 75 mg Aspirin + 4 mg BMS-986141 | 0 | 15 | |
| other | COVID-19 | Infections and infestations | Arm 3: 90 mg Ticagrelor + 75 mg Aspirin + 4 mg BMS-986141 | 0 | 16 | |
| other | COVID-19 | Infections and infestations | Arm 4: Heathy Participants | 1 | 11 | |
| other | Lower respiratory tract infection | Infections and infestations | Arm 1: 90 mg Ticagrelor + 4 mg BMS-986141 | 1 | 16 | |
| other | Lower respiratory tract infection | Infections and infestations | Arm 2: 75 mg Aspirin + 4 mg BMS-986141 | 0 | 15 | |
| other | Lower respiratory tract infection | Infections and infestations | Arm 3: 90 mg Ticagrelor + 75 mg Aspirin + 4 mg BMS-986141 | 0 | 16 | |
| other | Lower respiratory tract infection | Infections and infestations | Arm 4: Heathy Participants | 0 | 11 | |
| other | Contusion | Injury, poisoning and procedural complications | Arm 1: 90 mg Ticagrelor + 4 mg BMS-986141 | 0 | 16 | |
| other | Contusion | Injury, poisoning and procedural complications | Arm 2: 75 mg Aspirin + 4 mg BMS-986141 | 0 | 15 | |
| other | Contusion | Injury, poisoning and procedural complications | Arm 3: 90 mg Ticagrelor + 75 mg Aspirin + 4 mg BMS-986141 | 2 | 16 | |
| other | Contusion | Injury, poisoning and procedural complications | Arm 4: Heathy Participants | 0 | 11 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05093790/events